Digital render of Novo Nordisk's manufacturing expansion in Clayton, NC (Credit: Novo Nordisk)

No­vo Nordisk bud­gets $4.1B for new US man­u­fac­tur­ing site as it aban­dons plans for Irish build

No­vo Nordisk is fur­ther boost­ing man­u­fac­tur­ing in the US for its obe­si­ty drugs as it in­jects $4.1 bil­lion for a sec­ond fill-fin­ish fa­cil­i­ty in Clay­ton …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.